SREBF1 and hepatocellular carcinoma: These findings suggested that DHMMF may inhibit lipid synthesis in human HCC cells by modulating the functions of SREBP1 and its downstream proteins ACC, FASN and SCD1, thus exerting anti‐HCC effects.